Palvella Therapeutics
Price & Volume
Stats
See more52W Range | $11.17-$83 |
Market Cap | $860.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.53 |
News
See moreYahoo Finance • 3 days ago
Palvella Therapeutics to Present at the Stifel 2025 Healthcare Conference
Yahoo Finance • 27 days ago
U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics’ Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations
Yahoo Finance • last month
These Were the Russell 2000 Stocks That Dominated In Q3 2025
About
CEO | Mr. Wesley H. Kaupinen |
CFO | Mr. Matthew E. Korenberg |
Address | 125 Strafford Avenue, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
